We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current 0RO5 market cap is 17.75B. The company's latest EPS is RON 0.0471 and P/E is 709.13.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| RON (RON) | RON (RON) | RON (RON) | RON (RON) | RON (RON) | |
| Total Revenue | 1.08B | 1.43B | 1.8B | 2.22B | 2.72B |
| Operating Income | 120M | 177.12M | 99.08M | 94.21M | 146.88M |
| Net Income | 56.7M | 102.61M | 32.17M | 3.68M | 25.04M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| RON (RON) | RON (RON) | RON (RON) | RON (RON) | RON (RON) | |
| Total Assets | 1.18B | 1.42B | 2.15B | 2.64B | 3.02B |
| Total Liabilities | 914.59M | 1.04B | 1.67B | 2.14B | 2.51B |
| Total Equity | 268.91M | 381.41M | 482.04M | 494.19M | 504.65M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| RON (RON) | RON (RON) | RON (RON) | RON (RON) | RON (RON) | |
| Operating | 128.66M | 227.4M | 184.62M | 183.51M | 285.62M |
| Investing | -112.85M | -151.08M | -485.91M | -286.5M | -307.52M |
| Financing | 28.47M | -22.43M | 254.5M | 114.2M | 34.44M |
| Market Cap | 17.75B |
| Price to Earnings Ratio | 709.13 |
| Price to Sales Ratio | 6.52 |
| Price to Cash Ratio | 157.32 |
| Price to Book Ratio | 35.18 |
| Dividend Yield | - |
| Shares Outstanding | 531.48M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 300.00% |
| 52 Week High | 33.40 |
| 52 Week Low | 8.35 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Med Life Sa |
| Address |
calea grivitei, nr. 365, sector 1, bucuresti bucharest |
| Website | https://www.medlife.ro |
| Industry | offices of medical doctors (8011) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
